Testmiljö
Observera att detta är en testmiljö för utveckling som inte ska användas som underlag för klinisk bedömning. Besök Janusmed här: https://janusmed.se

11/21/2024

Janusmed amning

Janusmed amning – Olanzapin Bluefish

Janusmed amning tillhandahåller generella rekommendationer om huruvida ett friskt fullgånget spädbarn kan ammas när modern använder olika läkemedel. Observera att prematura och/eller sjuka spädbarn alltid kräver särskilda överväganden. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed amning och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Olanzapin Testmiljö

Olanzapin

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Gardiner SJ, Kristensen JH, Begg EJ, Hackett LP, Wilson DA, Ilett KF et al. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry 2003;160(8):1428-1431.

  2. Croke S, Buist A, Hackett LP, Ilett KF, Norman TR, Burrows GD. Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol 2002;5(3):243-247.

  3. Stiegler A, Schaletzky R, Walter G, Wüst R, Abele H, Goelz R et al. Olanzapine treatment during pregnancy and breastfeeding: a chance for women with psychotic illness?. Psychopharmacology (Berl). 2014;231:3067-9.

  4. L.Var, I.Ince, A.Topuzoglu, A.Yildiz. Management of postpartum manic episode without cessation of breastfeeding: a longitudinal follow up of drug excretion into breast milk. Eur Neuropsychopharmacol 2013;23 Suppl 2:382.

  5. Kirchheiner J, Berghofer A, Bolk-Weischedel D. Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry 2000;33(2):78-80.

  6. Whitworth A, Stuppaeck C, Yazdi K, Kralovec K, Geretsegger C, Zernig G et al. Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months. J Psychopharmacol. 2010;24:121-3.

  7. Lutz UC, Wiatr G, Orlikowsky T, Gaertner HJ, Bartels M. Olanzapine treatment during breast feeding: a case report. Ther Drug Monit. 2008;30:399-401.

  8. Gilad O, Merlob P, Stahl B, Klinger G. Outcome of infants exposed to olanzapine during breastfeeding. Breastfeed Med. 2011;6:55-8.

  9. Drugline nr 20197, 2003-07-28.

  10. Uguz F. Breastfed Infants Exposed to Combined Antipsychotics: Two Case Reports. Am J Ther. 2016;23(6):e1962-e1964.

  11. Manouilenko I, Öhman I, Georgieva J. Long-acting olanzapine injection during pregnancy and breastfeeding: a case report. Arch Womens Ment Health. 2018.

  12. Sinha SK, Kishore MT, Thippeswamy H, Kommu JVS, Chandra PS. Adverse effects and short-term developmental outcomes of infants exposed to atypical antipsychotics during breastfeeding. Indian J Psychiatry. 2021;63(1):52-57.

  13. Aydin B, Nayir T, Sahin S, Yildiz A. Olanzapine and quetiapine use during breastfeeding: excretion into breast milk and safe breastfeeding strategy. J Clin Psychopharmacol. 2015;35:206-8.

  1. Gardiner SJ, Kristensen JH, Begg EJ, Hackett LP, Wilson DA, Ilett KF et al. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry 2003;160(8):1428-1431.
  2. Croke S, Buist A, Hackett LP, Ilett KF, Norman TR, Burrows GD. Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol 2002;5(3):243-247.
  3. Stiegler A, Schaletzky R, Walter G, Wüst R, Abele H, Goelz R et al. Olanzapine treatment during pregnancy and breastfeeding: a chance for women with psychotic illness?. Psychopharmacology (Berl). 2014;231:3067-9.
  4. L.Var, I.Ince, A.Topuzoglu, A.Yildiz. Management of postpartum manic episode without cessation of breastfeeding: a longitudinal follow up of drug excretion into breast milk. Eur Neuropsychopharmacol 2013;23 Suppl 2:382.
  5. Kirchheiner J, Berghofer A, Bolk-Weischedel D. Healthy outcome under olanzapine treatment in a pregnant woman. Pharmacopsychiatry 2000;33(2):78-80.
  6. Whitworth A, Stuppaeck C, Yazdi K, Kralovec K, Geretsegger C, Zernig G et al. Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months. J Psychopharmacol. 2010;24:121-3.
  7. Lutz UC, Wiatr G, Orlikowsky T, Gaertner HJ, Bartels M. Olanzapine treatment during breast feeding: a case report. Ther Drug Monit. 2008;30:399-401.
  8. Gilad O, Merlob P, Stahl B, Klinger G. Outcome of infants exposed to olanzapine during breastfeeding. Breastfeed Med. 2011;6:55-8.
  9. Drugline nr 20197, 2003-07-28.
  10. Uguz F. Breastfed Infants Exposed to Combined Antipsychotics: Two Case Reports. Am J Ther. 2016;23(6):e1962-e1964.
  11. Manouilenko I, Öhman I, Georgieva J. Long-acting olanzapine injection during pregnancy and breastfeeding: a case report. Arch Womens Ment Health. 2018.
  12. Sinha SK, Kishore MT, Thippeswamy H, Kommu JVS, Chandra PS. Adverse effects and short-term developmental outcomes of infants exposed to atypical antipsychotics during breastfeeding. Indian J Psychiatry. 2021;63(1):52-57.
  13. Aydin B, Nayir T, Sahin S, Yildiz A. Olanzapine and quetiapine use during breastfeeding: excretion into breast milk and safe breastfeeding strategy. J Clin Psychopharmacol. 2015;35:206-8.

Innehållet senast uppdaterat 11/7/2024